Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Trading Up ∞
The firm has a market cap of C$21.54 million and a P/E ratio of -12.66. The firm has a fifty day simple moving average of C$2.00 and a 200-day simple moving average of C$2.00. The company has a debt-to-equity ratio of 8.19, a current ratio of 0.12 and a quick ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Read More
- Five stocks we like better than Liberty Biopharma
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- What is a Bond Market Holiday? How to Invest and Trade
- NVIDIA Insiders Sell: This Is What It Means for the Market
- Why Are These Companies Considered Blue Chips?
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
